Table: Phoenixbio - 6-MTH group results

PhoenixBio

14/11/2019 06:30

Nov 14 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2019        Sep 30, 2018      Mar 31, 2020  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            521 mln             426 mln            1.37      
                 (+22.3 pct)         (+34.9 pct)       (+11.3 pct)  
  Operating     loss 165 mln        loss 265 mln       loss 87 mln  
  Recurring     loss 155 mln        loss 249 mln       loss 57 mln  
  Net           loss 156 mln        loss 251 mln       loss 59 mln  
  EPS          loss 53.54 yen      loss 86.18 yen    loss 20.45 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T